177 related articles for article (PubMed ID: 38239355)
1. Metabolomics-transcriptomics joint analysis: unveiling the dysregulated cell death network and developing a diagnostic model for high-grade neuroblastoma.
Zhang W; Zhang M; Sun M; Hu M; Yu M; Sun J; Zhang X; Du B
Front Immunol; 2023; 14():1345734. PubMed ID: 38239355
[TBL] [Abstract][Full Text] [Related]
2. Joint analysis of the metabolomics and transcriptomics uncovers the dysregulated network and develops the diagnostic model of high-risk neuroblastoma.
Du B; Zhang F; Zhou Q; Cheng W; Yu Z; Li L; Yang J; Zhang X; Zhou C; Zhang W
Sci Rep; 2023 Oct; 13(1):16991. PubMed ID: 37813883
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic profiling in neuroblastoma.
Quintás G; Yáñez Y; Gargallo P; Juan Ribelles A; Cañete A; Castel V; Segura V
Pediatr Blood Cancer; 2020 Mar; 67(3):e28113. PubMed ID: 31802629
[TBL] [Abstract][Full Text] [Related]
4. Artificial neural network classifier predicts neuroblastoma patients' outcome.
Cangelosi D; Pelassa S; Morini M; Conte M; Bosco MC; Eva A; Sementa AR; Varesio L
BMC Bioinformatics; 2016 Nov; 17(Suppl 12):347. PubMed ID: 28185577
[TBL] [Abstract][Full Text] [Related]
5. Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma.
Kling MJ; Griggs CN; McIntyre EM; Alexander G; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK
BMC Cancer; 2021 Sep; 21(1):1061. PubMed ID: 34565342
[TBL] [Abstract][Full Text] [Related]
6. ISL1 promoted tumorigenesis and EMT via Aurora kinase A-induced activation of PI3K/AKT signaling pathway in neuroblastoma.
Li M; Sun C; Bu X; Que Y; Zhang L; Zhang Y; Zhang L; Lu S; Huang J; Zhu J; Wang J; Sun F; Zhang Y
Cell Death Dis; 2021 Jun; 12(6):620. PubMed ID: 34131100
[TBL] [Abstract][Full Text] [Related]
7. MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment.
Garcia-Gerique L; García M; Garrido-Garcia A; Gómez-González S; Torrebadell M; Prada E; Pascual-Pasto G; Muñoz O; Perez-Jaume S; Lemos I; Salvador N; Vila-Ubach M; Doncel-Requena A; Suñol M; Carcaboso AM; Mora J; Lavarino C
BMC Cancer; 2022 Jun; 22(1):669. PubMed ID: 35715791
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Characterization of Circular RNAs in Neuroblastoma Cell Lines.
Zhang L; Zhou H; Li J; Wang X; Zhang X; Shi T; Feng G
Technol Cancer Res Treat; 2020; 19():1533033820957622. PubMed ID: 33000697
[TBL] [Abstract][Full Text] [Related]
9. The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma.
Amoroso F; Capece M; Rotondo A; Cangelosi D; Ferracin M; Franceschini A; Raffaghello L; Pistoia V; Varesio L; Adinolfi E
Oncogene; 2015 Oct; 34(41):5240-51. PubMed ID: 25619831
[TBL] [Abstract][Full Text] [Related]
10.
Jin Q; Chen Y; Du S; Xu D; Yue J; Cai L; Yuan X
Curr Cancer Drug Targets; 2022; 22(11):919-930. PubMed ID: 35909289
[TBL] [Abstract][Full Text] [Related]
11. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
Yang XH; Tang F; Shin J; Cunningham JM
BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
[TBL] [Abstract][Full Text] [Related]
12. Polo-like kinase 4 mediates epithelial-mesenchymal transition in neuroblastoma via PI3K/Akt signaling pathway.
Tian X; Zhou D; Chen L; Tian Y; Zhong B; Cao Y; Dong Q; Zhou M; Yan J; Wang Y; Qiu Y; Zhang L; Li Z; Wang H; Wang D; Ying G; Zhao Q
Cell Death Dis; 2018 Jan; 9(2):54. PubMed ID: 29352113
[TBL] [Abstract][Full Text] [Related]
13. Level of Seven Neuroblastoma-Associated mRNAs Detected by Droplet Digital PCR Is Associated with Tumor Relapse/Regrowth of High-Risk Neuroblastoma Patients.
Thwin KKM; Ishida T; Uemura S; Yamamoto N; Lin KS; Tamura A; Kozaki A; Saito A; Kishimoto K; Mori T; Hasegawa D; Kosaka Y; Nino N; Takafuji S; Iijima K; Nishimura N
J Mol Diagn; 2020 Feb; 22(2):236-246. PubMed ID: 31837427
[TBL] [Abstract][Full Text] [Related]
14. Integration of clinical characteristics and molecular signatures of the tumor microenvironment to predict the prognosis of neuroblastoma.
Cheng H; Zhang L; Yang S; Ren Q; Chang S; Jin Y; Mou W; Qin H; Yang W; Zhang X; Zhang W; Wang H
J Mol Med (Berl); 2023 Nov; 101(11):1421-1436. PubMed ID: 37712965
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of the functions and prognostic values of RNA-binding proteins in neuroblastoma.
Yang J; Zhou J; Li C; Wang S
PLoS One; 2021; 16(12):e0260876. PubMed ID: 34879089
[TBL] [Abstract][Full Text] [Related]
16. Absence of MGST1 mRNA and protein expression in human neuroblastoma cell lines and primary tissue.
Kelner MJ; Diccianni MB; Yu AL; Rutherford MR; Estes LA; Morgenstern R
Free Radic Biol Med; 2014 Apr; 69():167-71. PubMed ID: 24486338
[TBL] [Abstract][Full Text] [Related]
17. Analysis and identification of novel biomarkers involved in neuroblastoma via integrated bioinformatics.
Chen B; Ding P; Hua Z; Qin X; Li Z
Invest New Drugs; 2021 Feb; 39(1):52-65. PubMed ID: 32772341
[TBL] [Abstract][Full Text] [Related]
18. Differential Plasma Metabolites between High- and Low-Grade Meningioma Cases.
Kurokawa GA; Hamamoto Filho PT; Delafiori J; Galvani AF; de Oliveira AN; Dias-Audibert FL; Catharino RR; Pardini MIMC; Zanini MA; Lima EO; Ferrasi AC
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613836
[TBL] [Abstract][Full Text] [Related]
19. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
20. Combined analysis of RNA-sequence and microarray data reveals effective metabolism-based prognostic signature for neuroblastoma.
Meng X; Feng C; Fang E; Feng J; Zhao X
J Cell Mol Med; 2020 Sep; 24(18):10367-10381. PubMed ID: 32683778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]